English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51884654    線上人數 :  845
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"liao w y"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 56-65 / 352 (共36頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-04-28T08:06:30Z The unmet supportive care needs—what advanced lung cancer patients’ caregivers need and related factors Chen S.-C.; Chiou S.-C.; Yu C.-J.; Lee Y.-H.; Liao W.-Y.; Hsieh P.-Y.; Jhang S.-Y.; YEUR-HUR LAI
臺大學術典藏 2022-04-28T08:06:27Z Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancer Lee Y.-H.; Liao Y.-C.; Shun S.-C.; Lin K.-C.; Liao W.-Y.; Chang P.-H.; Jhang S.-Y.; Yu C.-J.; Yang P.-C.; Hsieh P.-Y.; YEUR-HUR LAI
臺大學術典藏 2022-03-09T03:12:36Z TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer Ho C.-C.; Liao W.-Y.; Wang C.-Y.; Lu Y.-H.; Huang H.-Y.; Chen H.-Y.; Chan W.-K.; HUEI-WEN CHEN; Yang P.-C.
臺大學術典藏 2022-03-04T05:33:49Z The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms Chang Y.-L.; Lee Y.-C.; Liao W.-Y.; CHEN-TU WU
臺大學術典藏 2022-03-04T05:33:28Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2022-03-04T05:33:27Z Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2022-03-04T03:48:05Z Tubulointerstitial nephritis associated with erlotinib therapy for lung cancer Cho S.-L.; WEI-CHOU LIN; Chuang C.-A.; Liao W.-Y.; Lai C.-F.
臺大學術典藏 2022-02-21T03:52:35Z Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; JIH-HSIANG LEE; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏 2022-02-21T03:52:35Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2022-02-21T03:52:34Z Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients Wu T.-H.; Hsiue E.H.-C.; JIH-HSIANG LEE; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.

顯示項目 56-65 / 352 (共36頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目